Results 1 to 10 of about 8,275 (249)
Is adiponectin involved in morphea pathogenesis? – first observational study [PDF]
Frontiers in ImmunologyBackgroundMorphea is a chronic inflammatory condition characterized by fibrosis of the skin and/or subcutaneous tissues. Adiponectin is an adipokine known for its anti-inflammatory and antifibrotic properties.
Adriana Polańska +5 more
doaj +4 more sources
Small-sized shiny sclerotic plaques: Think early morphea [PDF]
European Journal of Inflammation, 2022 Morphea is a rare fibrosing disorder of the skin and underlying tissues. To date, the size of morphea has not been adequately discussed. Here, we report two cases of small-sized superficial circumscribed morphea.
Hiroki Hashimoto, Takeshi Nakahara
doaj +2 more sources
Granulomatous fasciitis followed by morphea profunda: Is granulomatous fasciitis part of a spectrum of deep morphea? A case report and review of the literature [PDF]
Clinical Case Reports, 2018 Key Clinical Message Although eosinophilic fasciitis is known to be part of the deep morphea spectrum, this first report of the coexistence of granulomatous fasciitis and morphea profunda suggests that granulomatous fasciitis may also be a part of the ...
Angie Christensen +5 more
doaj +2 more sources
Muscle weakness in a 4-year-old girl: A rare presentation of deep morphea
Indian Journal of Paediatric Dermatology, 2021 Introduction: Morphea is a rare fibrosing disorder of the skin and underlying tissues. Deep morphea involves the deep dermis, subcutis, fascia, muscle, and bone. The above structures may be involved independently or in combination.
Mary Augustine, Sumedha Ballal
doaj +2 more sources
Turkderm Turkish Archives of Dermatology and Venereology, 2022 Background and Design: Morphea is also known as localized scleroderma. It is a rare autoimmune skin disease characterized by inflammation and sclerosis in the dermis and sometimes in the subcutaneous tissue.
Yıldız Gürsel Ürün +1 more
doaj +2 more sources
Laser therapy in superficial morphea lesions – indications, limitations and therapeutic alternatives [PDF]
Journal of Mind and Medical Sciences, 2020 Morphea or localized scleroderma is an uncommon autoimmune and inflammatory disease which affects patients of any age. Even if morphea lesions present systemic symptoms as myalgias or arthritis, it is distinct from systemic sclerosis because it does not ...
Alin Laurentiu Tatu +4 more
doaj +2 more sources
Immunohistochemical Similarities between Lichen Sclerosus et Atrophicus and Morphea: A Case Study [PDF]
Case Reports in Dermatology, 2015 Both morphea and lichen sclerosus et atrophicus (LSA) are connective tissue diseases that mainly affect the skin. A recent report suggested that a substantial portion of morphea coexists with LSA.
Aya Kakizaki +4 more
doaj +2 more sources
Upcoming treatments for morphea
Immunity, Inflammation and Disease, 2021 Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4–2.7 cases per 100,000.
Ahmad Reza Dehpour +2 more
exaly +2 more sources
Quality of Life and Optimism in Patients with Morphea [PDF]
, 2013 Despite extensive knowledge about quality of life of people suffering from dermatological diseases, data on patients with morphea are scarce. The aim of our study was to compare the quality of life of healthy controls and morphea patients, as well as to ...
Aleksandra Dańczak-Pazdrowska +5 more
core +3 more sources
Autoantibodies in Morphea: An Update
Frontiers in Immunology, 2019 Skin autoimmune conditions belong to a larger group of connective tissue diseases and primarily affect the skin, but might also involve underlying tissues, such as fat tissue, muscle, and bone.
Sangita Khatri +2 more
exaly +3 more sources